Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vitamin E - Nutraceuticals World
Research

Vitamin E

Indication: Alzheimer’s disease

Source: New England Journal of Medicine, April 14, 2005 online edition (appeared in June 9th print edition)

Research: As part of the study, re­searchers examined the effect of donepezil (a drug prescribed for mild to moderate stages of Alzheimer’s disease) and vitamin E on delaying diagnosis of Alzheimer’s disease among a subset of people with mild cognitive impairment (MCI) with apolipoprotein E-4 (APOE-4), the only known genetic risk factor for late-onset Alzheimer’s disease. Participants were randomized to three groups, one taking 2000 IU daily of vitamin E, the second receiving 10 mg of donepezil daily, and the third taking a placebo. All participants also took daily multivitamins. The average age of the participants at baseline was 73 years.

Results: Among the 769 study participants enrolled at 69 sites in the U.S. and Canada, 212 developed possible or probable Alzheimer’s disease within the 3-year study period. The overall rate of progression from MCI to Alzheimer’s disease for all three treatment groups combined was 16% per year. The study found that the donepezil group’s risk of progression to a diagnosis of Alz­heimer’s disease was reduced by 58% 1 year into the study, 36% at 2 years, but there was no risk reduction at the end of the full 3 years of the study. Vitamin E was found to have no effect at any time in the study when compared with placebo.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters